Bayer US Patient Assistance Foundation

Funded
About
The Bayer US Patient Assistance Foundation offers a comprehensive patient assistance program for individuals in need of medication support, explicitly targeting drugs such as Adempas, Kovaltry, Jivi, Betaseron, Vitrakvi, Xofigo, Stivarga, Nubeqa, Mirena, Skyla, and Kyleena. This program is designed to aid patients residing in the United States with limited or no prescription insurance, ensuring access to necessary medications through income-based guidelines.
Insurance requirements: Underinsured, Uninsured
Enrollment Forms
Bayer US Patient Assistance Foundation
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Patients should first seek any available state or government assistance before applying to this program; the patient may be asked to supply paperwork supporting the denial of assistance from these programs
Patients must mail or fax completed application (by patient & HCP) and proof of income to: : Bayer US Patient Assistance Foundation, P.O. Box 5670, Louisville, KY 40255 Fax: 18665756568
Patients/HCP/Caregiver may also enroll online at: https://hubconnect.mckesson.com/e4iyhje6xp9780bayer
If patient enrolls in Medicare Part D Prescription Drug Benefit Plan, they will still be eligible to receive free medication for calendar year
For questions, please call a Bayer US Patient Assistance Foundation representative at 18662287723, MondayFriday 9 AM6 PM EST
Other Tools for
Check Drug Interactions